Why Complete Dose Availability Matters for Your Treatment
Complete Wegovy Mounjaro Dose Comparison: Your Entire Journey Covered
When comparing Wegovy and Mounjaro dosing schedules, continuity of supply becomes crucial for treatment success. Both prescription-only medicines require structured dose escalation over 16 weeks, making pharmacy consistency essential. EverydayMeds stocks every dose strength—from 0.25mg starter doses through to 2.4mg maintenance—ensuring you never face treatment interruptions due to stock shortages elsewhere. This comprehensive approach to Wegovy Mounjaro dose comparison means one pharmacy relationship covers your complete weight management journey.
The escalation timeline remains identical for both treatments: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg (week 17 onwards). However, their mechanisms differ significantly—Wegovy targets GLP-1 receptors exclusively, while Mounjaro activates both GIP and GLP-1 pathways. Understanding this Wegovy Mounjaro dose comparison helps inform treatment selection alongside your prescriber's guidance. Both medications must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Transparent Pricing Across All Dose Strengths
Our Wegovy Mounjaro dose comparison includes complete pricing transparency across all strengths. Single pens start from £79.99 for 0.25mg starter doses, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for 2.4mg maintenance doses. These prices reflect final costs after applying discount codes FIRST40 for new customers and DOSE25 for returning customers at checkout. Bundle options provide convenient multi-dose packages—our Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Ultimate Stability Trio offers three months of maintenance supply at £649.99.
This comprehensive pricing structure eliminates surprises when progressing through dose escalation. Whether choosing Wegovy or Mounjaro following your clinical assessment, transparent costs enable informed treatment planning. Our GPhC-registered pharmacy (#9012878) ensures legitimate supply with full UK regulatory compliance. Bundle pricing offers convenience through reduced ordering frequency and Reliable Supply continuity, particularly valuable for maintenance dosing where treatment consistency proves essential for sustained weight management outcomes.
Clinical Evidence Supporting Dose Escalation Protocols
The structured dose escalation in our Wegovy Mounjaro dose comparison reflects clinical trial methodologies proving treatment efficacy. STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with STEP 5 showing sustained clinically studied weight loss at two years (Wilding et al., NEJM, 2021). The gradual dose increases help minimise gastrointestinal side effects while optimising therapeutic response.
Similar dose escalation principles apply to Mounjaro, though direct head-to-head comparisons remain limited due to different trial designs and patient populations. Both treatments require this careful titration schedule—starting at 0.25mg weekly allows tolerance development before progressing to therapeutic doses. Clinical assessments at EverydayMeds ensure appropriate treatment selection based on individual patient factors and medical history.
Understanding How Wegovy Works Throughout Dose Escalation
Wegovy's semaglutide works as a GLP-1 receptor agonist, mimicking natural hormones that regulate appetite and food intake. As doses increase from 0.25mg through to 2.4mg maintenance, the medication progressively enhances feelings of fullness after smaller meals while reducing food cravings through actions on brain appetite centres. This mechanism explains why gradual dose increases prove essential—allowing the body to adapt while minimising potential side effects. The weekly injection using Novo Nordisk's FlexTouch pen provides consistent medication levels throughout each dosing interval. Higher doses generally correlate with enhanced appetite suppression, though individual responses vary significantly between patients.
Streamlined Ordering Process for All Dose Strengths
Accessing any dose in our Wegovy Mounjaro dose comparison begins with a 3-minute online clinical assessment covering medical history, current medications, and treatment goals. Our prescribers review applications within 3 working days (24-hour express service available), ensuring thorough evaluation before approving treatment. Once approved, next-day delivery utilises cold-chain logistics maintaining required temperatures throughout transport. This process applies whether starting at 0.25mg or progressing to maintenance doses—the same rigorous clinical governance protects patient safety across all treatment stages. GPhC registration (#9012878) ensures legitimate supply channels with full MHRA compliance.
Storage and Practical Considerations for Both Treatments
Storage requirements present key differences in our Wegovy Mounjaro dose comparison. Wegovy maintains potency for 6 weeks at room temperature below 30°C after removing from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require 2-8°C refrigerated storage before first use, but Wegovy's extended temperature tolerance offers practical advantages for travel or temporary storage situations. The FlexTouch pen design enables straightforward weekly self-injection, with dose escalation requiring different pen strengths rather than volume adjustments. This system reduces dosing errors while ensuring accurate medication delivery throughout the treatment journey.
Long-term Maintenance Dose Planning and Supply Security
Reaching 2.4mg maintenance dosing represents a significant milestone, typically occurring at week 17 of treatment. At this stage, our Wegovy Mounjaro dose comparison shifts towards long-term supply planning and treatment sustainability. The Ultimate Stability Trio provides three 2.4mg pens for £649.99, offering quarterly supply convenience while ensuring consistent treatment continuation. Maintenance dosing may continue indefinitely under medical supervision, making reliable pharmacy relationships increasingly valuable.
Supply security becomes paramount during maintenance phases—treatment interruptions can affect weight management progress and may require dose re-escalation. EverydayMeds' comprehensive stock levels across all dose strengths eliminate these concerns, providing treatment continuity from initial 0.25mg doses through long-term maintenance. This approach supports the chronic nature of weight management, where sustained medication access proves essential for maintaining clinical benefits achieved during dose escalation.
Expert Support Throughout Your Treatment Journey
Our comprehensive approach to Wegovy Mounjaro dose comparison extends beyond simple supply—expert clinical support guides treatment decisions at every stage. Both Wegovy and Mounjaro are available from EverydayMeds, with prescribers helping determine the most appropriate option based on individual patient factors, medical history, and treatment goals. Ready to begin your weight management journey with complete dose availability and transparent pricing? Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment today, applying discount code FIRST40 for new customers or DOSE25 for returning patients at checkout. Our GPhC-registered pharmacy (#9012878) ensures safe, legitimate treatment supply with next-day delivery nationwide, supporting your long-term weight management success from first dose through maintenance therapy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
